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ORIGINAL INVESTIGATION
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independently associated with left ventricular 
filling pressure in patients with type 2 diabetes 
mellitus
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Abstract 
Background: Left ventricular (LV) diastolic dysfunction is known as an early marker of myocardial alterations in 
patients with diabetes. Because microvascular disease has been regarded as an important cause of heart failure or 
diastolic dysfunction in diabetic patients, we tested the hypothesis that coronary flow reserve (CFR), which reflects 
coronary microvascular function, is associated with LV diastolic dysfunction in patients with type 2 diabetes.
Methods: We studied asymptomatic patients with type 2 diabetes but without overt heart failure. Transthoracic 
Doppler echocardiography was performed that included pulsed tissue Doppler of the mitral annulus and CFR of the 
left anterior descending artery (induced by adenosine 0.14 mg/kg/min). The ratio of mitral velocity to early diastolic 
velocity of the mitral annulus (E/e′) was used as a surrogate marker of diastolic function. We also evaluated renal func‑
tion, lipid profile, parameters of glycemic control and other clinical characteristics to determine their association with 
E/e′. Patients with LV ejection fraction <50%, atrial fibrillation, valvular disease, regional wall motion abnormality, renal 
failure (serum creatinine >2.0 mg/dl) or type 1 diabetes were excluded. Patients with a CFR <2.0 were also excluded 
based on the suspicion of significant coronary artery stenosis.
Results: We included 67 asymptomatic patients with type 2 diabetes and 14 non‑diabetic controls in the final study 
population. In univariate analysis, age, presence of hypertension, LV mass index, estimated glomerular filtration rate 
and CFR were significantly associated with E/e′. Multivariate analysis indicated that both LV mass index and CFR were 
independently associated with E/e′. In contrast, there were no significant associations between parameters of glyce‑
mic control and E/e′.
Conclusions: CFR was associated with LV filling pressure in patients with type 2 diabetes. This result suggests a pos‑
sible link between coronary microvascular disease and LV diastolic function in these subjects.
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Background
Epidemiologic studies have shown that patients with dia-
betes mellitus have a two to fourfold increased risk of 
cardiovascular mortality [1]. With regard to heart failure, 
the Framingham study [2] revealed that the risk for con-
gestive heart failure is greatly increased in patients with 
diabetes, and this is independent of underlying coronary 
artery disease and other cardiovascular risk factors. Dia-
betes also directly contributes to the development of left 
ventricular (LV) hypertrophy, which also predicts car-
diac morbidity and mortality [3–5]. Moreover, numer-
ous reports have identified LV diastolic dysfunction using 
echocardiography as a major early feature of myocardial 
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damage in patients with diabetes [6–8]. Indeed, diastolic 
parameters are related to prognosis in diabetic patients 
without overt heart disease [9, 10].
Although the exact causes of LV myocardial damage in 
patients with diabetes (so called diabetic cardiomyopa-
thy) remain unclear, several factors such as a metabolic 
abnormality, autonomic dysfunction, myocardial fibrosis 
and reduced perfusion due to small vessel disease, have 
been reported as potential mechanisms of myocardial 
damage in diabetic patients [11, 12]. Small vessel disease 
that causes diabetic retinopathy represents an increased 
risk of heart failure that is independent of known risk 
factors [13], since diabetic retinopathy is significantly 
associated with LV diastolic dysfunction [14]. Further-
more, there is much less coronary flow reserve (CFR) 
in diabetic patients with than without retinopathy [15]. 
CFR, the ratio of hyperemic to basal coronary blood flow 
velocity, is a physiological parameter that reflects coro-
nary microvascular function in the absence of large vessel 
stenosis [16], and many reports have described the utility 
of measuring CFR by noninvasive transthoracic Doppler 
echocardiography in various diseases including diabetes 
[17–21]. Therefore, we tested the hypothesis that CFR 
assessed by transthoracic echocardiography is associated 
with LV diastolic function in patients with type 2 diabetes 
without a history of heart failure.
Methods
Study subjects and protocol
The present study was a prospective, cross-sectional 
study. A total of 75 consecutive asymptomatic patients 
with type 2 diabetes (57 male; mean age, 57 ± 12 years), 
who were admitted to our institution (Juntendo Univer-
sity Hospital, Tokyo, Japan) for a diabetic educational 
program were enrolled. In addition, 14 age- and gender-
matched non-diabetic subjects were enrolled to serve as 
a control group. Patients were included if they met the 
following inclusion criteria: adult type 2 diabetes, no 
symptoms or history of cardiovascular disease, LV ejec-
tion fraction ≥50%, absence of regional LV wall motion 
abnormalities, and clinically stable. Exclusion criteria 
were: atrial fibrillation, history of cardiovascular disease, 
congenital heart disease, significant valvular disease, 
renal failure (serum creatinine >2.0  mg/dl), and type 1 
diabetes. Further, patients with CFR <2.0 or with a posi-
tive exercise stress test were also excluded from the study 
because of the suspicion of significant coronary artery 
stenosis [22, 23]. We performed coronary flow velocity 
measurement after conventional echocardiography and 
venous blood sampling. The study protocol was approved 
by the Institutional Review Board of Juntendo University 
Hospital.
Definition of diabetes and comorbidities
The diagnosis of diabetes was assured in all patients by 
determination of glucose in the fasting state based on 
the criteria of the World Health Organization [24]. Dys-
lipidemia was defined as low-density lipoprotein choles-
terol ≥ 140  mg/dl or high-density lipoprotein cholesterol 
< 40 mg/dl or triglycerides ≥ 150 mg/dl or already receiving 
medical treatment. Hypertension was defined as systolic 
blood pressure >140  mmHg or diastolic blood pressure 
>90 mmHg or already receiving medical treatment.
Exercise stress test
A standard double Master’s two-step test was performed to 
screen patients for significant coronary artery disease [25]. 
The test endpoint was either chest symptom or completion 
of the required number of steps within 3  min. A 12-lead 
electrocardiogram was recorded before, immediately after 
and at 3, 5, and 7 min after exercise. The test was consid-
ered positive if the ST segment (80 ms after the J point) was 
horizontal or had a downslope with a 1-mm depression.
Echocardiography
In all subjects, cardiac chamber quantification by 2D 
echocardiography was performed according to the 
American Society of Echocardiography guidelines [26]. 
LV diameters were measured using 2D echocardiography 
according to the recommended criteria. The thickness of 
the interventricular septum and the LV posterior wall was 
measured at end-diastole. LV mass was calculated using 
diastolic measurements of LV diameter and wall thick-
ness on 2D echocardiography according to the formula 
recommended by the guidelines. LV end-diastolic volume 
and end-systolic volume were determined from the apical 
views using modified biplane Simpson’s method. LV ejec-
tion fraction was calculated by the following equation: 
100  ×  (end-diastolic volume  −  end-systolic volume)/
end-diastolic volume. Each parameter was indexed for 
body surface area, when appropriate. For assessing con-
ventional diastolic parameters, mitral inflow velocities 
were determined by pulsed Doppler imaging. The peak 
early (E) and late (A) diastolic velocity, the deceleration 
time (DcT) from the peak of the early diastolic wave to 
baseline and the E/A ratio were assessed from the mitral 
inflow velocity pattern. The mitral annular motion veloc-
ity was recorded at the septal mitral annulus site in the 
apical 4-chamber view using pulsed tissue Doppler. Peak 
early diastolic velocity (e′) of the annulus was measured, 
and the ratio of peak early diastolic transmitral flow 
velocity to annular velocity (E/e′) was calculated. Since 
E/e′ has been accepted as a surrogate marker of LV filling 
pressure [27], particularly in heart failure with preserved 
ejection fraction, we used E/e′ as an index of diastolic 
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function in this study. Furthermore, according to previ-
ous reports [27, 28], we classified diastolic function in all 
study subjects into one of four categories (normal, grade 
I, grade II or grade III) to compare the prevalence of dias-
tolic dysfunction between controls and diabetic patients.
Laboratory measurements
Venous blood samples for determination of serum cre-
atinine, fasting blood sugar, glycosylated hemoglobin, 
immunoreactive insulin and lipid profiles (triglycerides, 
high-density lipoprotein cholesterol and low-density 
lipoprotein cholesterol) were drawn in all patients imme-
diately before the CFR measurement. Moreover, the 
homeostasis model assessment ratio (HOMA-R) index 
was calculated as fasting plasma glucose × fasting plasma 
insulin/405 for assessing insulin resistance [29]. Esti-
mated glomerular filtration rate (eGFR) was determined 
based on the new Japanese coefficient-modified Modifi-
cation of Diet in Renal Disease (MDRD) study equation 
[30]. The formula is as follows: eGFR = 194 × serum cre-
atinine (SCr)−1.094 × age-0.287, where age is in years, SCr 
is in mg/dL and GFR is in mL/min/1.73 m2 body surface 
area. The product of this equation was multiplied by a 
correction factor of 0.739 in women.
Measurement of CFR
Blood flow velocity in the distal portion of the left ante-
rior descending (LAD) coronary artery was measured 
with a high-frequency transducer (5–7 MHz) under color 
Doppler flow guidance. With a sample volume (2.5 or 
3.0 mm wide) positioned on the color signal in the LAD, 
Doppler spectral tracings of flow velocity in the LAD 
were recorded using a fast Fourier transformation. We 
first recorded baseline spectral Doppler signals in the 
LAD, then an intravenous adenosine was administered 
(0.14 mg/kg/min) to record spectral Doppler signals dur-
ing hyperemia (Fig. 1). Mean and peak diastolic velocities 
were measured at baseline and peak hyperemic conditions 
from the Doppler signal recordings. Measurements were 
averaged over three cardiac cycles. In this study, CFR was 
defined as the ratio of hyperemic to basal mean diastolic 
coronary flow velocity. To determine the reproducibility 
of mean diastolic velocity, a total of ten randomly selected 
measurements were analyzed twice by one investigator at 
a 1-week interval and once by another investigator.
Statistical analysis
All data are expressed as mean ±  standard deviation (SD) 
or the number (percent) of patients. Data in the diabetes 
patients and controls were compared using unpaired t test 
for continuous variables and Chi square test for categori-
cal variables. In patients with diabetes, univariate regres-
sion analysis was performed to determine the association 
between E/e′ and the following variables: age, gender, body 
mass index, presence of hypertension, rate pressure prod-
uct (systolic blood pressure × heart rate), LV ejection frac-
tion, LV mass index, eGFR, fasting blood sugar, glycosylated 
hemoglobin, HOMA-R, lipid profile and CFR. The vari-
ables that were significant in the univariate model were then 
entered into a multivariate regression analysis using a for-
ward stepwise method. A probability value of p < 0.05 was 
considered significant. All data were statistically analyzed 
using JMP version 8.0 (SAS Institute, Cary, NC, USA).
Results
Enrolled patients
Among 75 patients, 2 patients (3%) were excluded 
because they had LV ejection fraction <50%. None 
Fig. 1 Example of Doppler tracing of LAD blood flow during baseline and after adenosine injection (hyperemia).
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of the patients had a positive exercise stress test. Six 
patients (8%) had CFR <2.0. Therefore, the final study 
population consisted of 67 patients (50 male; mean age, 
57 ±  12 years) with type 2 diabetes who met the inclu-
sion criteria (Fig. 2). All 14 of the non-diabetic controls 
had CFR ≥2.0, LV ejection fraction ≥50%, no symptoms 
or history of cardiovascular disease, and no regional LV 
wall motion abnormalities.
Patient characteristics and echocardiographic data
Patients’ general characteristics, laboratory and echocar-
diographic data are summarized in Tables 1 and 2. Sev-
enty-four % of our study subjects were male. Although 
controls of blood pressure and lipid profile were ade-
quate, 57% had hypertension and 51% had dyslipidemia. 
About half of the patients were on inhibitors of the renin-
angiotensin system or statins. With respect to diabetes 
control, 51% of patients were receiving insulin by subcu-
taneous infusion. Patients with diabetes had a dilated left 
atrium, elevated E/e′ and impaired CFR compared with 
controls; however, the other characteristics and echocar-
diographic parameters were not different between the 
two groups. Figure  3 shows the distribution of diastolic 
dysfunction grade in diabetic patients and controls. Most 
of the patients (69%) had diastolic dysfunction, indicat-
ing a higher prevalence of diastolic dysfunction in the 
diabetic population. None of the subjects had grade III 
diastolic dysfunction.
CFR and clinical variables
Both age and RPP were significantly associated with CFR 
(age, β = −0.33, p = 0.0056; RPP, β = −0.31, p = 0.0095). 
There was a tendency for eGFR to be associated with CFR 
(β = 0.23, p = 0.057). There was no association between 
temporal glycemic control and CFR (fasting blood sugar, 
β = −0.11, p = 0.34; glycosylated hemoglobin, β = 0.053, 
p =  0.67; HOMA-R, β = −0.014, p =  0.39). Moreover, 
there were also no association between lipid profile and 
CFR (LDL-C, β =  0.10, p =  0.38; HDL-C, β = −0.014, 
p = 0.91; TG, β = −0.12, p = 0.31). CFR measured from 
peak diastolic velocity in diabetic patients was 3.3 ± 0.7. 
There was a strong correlation between CFR measured 
using mean diastolic flow velocity and CFR measured 
using peak diastolic flow velocity (r = 0.92, p < 0.0001). 
The inter- and intra-observer variabilities for the meas-
urement of coronary Doppler velocity were 5.0 and 3.9%, 
respectively.
Univariate and multivariate determinants of E/e′
Univariate and multivariate potential determinants of E/e′ 
were analyzed and summarized in Table 3. In univariate 
analysis, age, presence of hypertension, LV mass index, 
eGFR and CFR were significantly associated with E/e′. 
Female gender tended to show an association with high 
E/e′. Figure  4 shows the relation between CFR and E/e′; 
a significant inverse association between CFR and E/e′ 
was observed. CFR was also associated with e′, an index 
of myocardial relaxation (β  =  0.26, p  =  0.0319). There 
Asymptomatic patients with 
type 2 diabetes (n = 75) Excluded n = 2 
  Wall motion abnormarity (0) 
  LV ejection fraction < 50% (2) 
  Atrial fiblliration (0) 
  Significant valvular disease (0) 
2D echocardiography 
Stress electrocardiogram 
CFR measurement Excluded n = 6 
  CFR < 2.0 (6) 
Enrolled (n = 67) 
Excluded n = 0 
  Positive (0) 
Fig. 2 Patient flow diagram. Of the consecutive 75 patients who 
were studied, 8 were excluded. Sixty‑seven patients were enrolled 
and completed the entire protocol.
Table 1 General characteristics of the study population
Data are presented as number (%) or mean ± SD.
BMI body mass index, SBP/DBP systolic/diastolic blood pressure, HR heart rate, 
RPP rate pressure product, ACE inhibitor/ARB angiotensin-converting enzyme 
inhibitor/angiotensin-receptor blocker, CCB calcium channel blocker.
Variables Patients (n = 67) Controls (n = 14) p
Age (years) 57 ± 12 56 ± 10 0.74
Male (%) 50 (74) 9 (64) 0.31
BMI (kg/m2) 25.8 ± 4.6 24.4 ± 3.7 0.24
SBP (mmHg) 118 ± 17 124 ± 12 0.13
DBP (mmHg) 63 ± 12 68 ± 7 0.075
HR (bpm) 68 ± 11 68 ± 8 0.94
RPP 8034 ± 1713 8558 ± 1233 0.26
Hypertension (%) 38 (57) 9 (64) 0.42
Dyslipidemia (%) 34 (51) 8 (57) 0.44
Diabetes treatment
 Diet (%) 10 (15) –
 Sulfonylurea (%) 11 (16) –
 Glinide (%) 9 (13) –
 Biguanide (%) 22 (33) –
 Thiazolidinedione (%) 9 (13) –
 α‑glucosidase inhibitor 
(%)
23 (34) –
 Insulin (%) 34 (51) –
Other treatment
 Statin (%) 30 (45) 5 (36) 0.38
 ACE inhibitor/ARB (%) 34 (51) 5 (36) 0.23
 CCB (%) 23 (34) 7 (50) 0.21
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were no significant associations between E/e′ and param-
eters of glycemic control such as fasting blood sugar, gly-
cosylated hemoglobin or HOMA-R. Multivariate analysis 
(including age, presence of hypertension, LV mass index, 
eGFR and CFR) showed that both LV mass index and CFR 
were independent determinants of E/e′ (Table 3).
Discussion
The key finding of the present study was that CFR was 
independently and inversely associated with E/e′, a sur-
rogate marker of LV filling pressure, in patients with type 
2 diabetes without overt cardiovascular disease.
Earlier studies have demonstrated that microalbuminu-
ria caused by diabetic nephropathy is strongly associated 
with cardiovascular disease and mortality [31]. Moreover, 
Table 2 Laboratory and echocardiographic data
Data are presented as mean ± SD.
FBS fasting blood sugar, HbA1c glycated hemoglobin, IRI immunoreactive 
insulin, HOMA-R homeostasis model assessment ratio, T-Cho total-cholesterol, 
HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein 
cholesterol, eGFR estimated glomerular filtration rate, RWT relative wall 
thickness, LVEDV/ESV left ventricular end-diastolic volume/end-systolic volume, 
LVEF left ventricular ejection fraction, DT deceleration time of mitral E wave, MDV 
mean diastolic coronary flow velocity, CFR coronary flow reserve.






 FBS (mg/dl) 130.9 ± 40.1 97.0 ± 6.7 <0.0001
 HbA1c (%) 7.8 ± 1.5 5.2 ± 0.2 <0.0001
 IRI (µU/l) 8.8 ± 8.3 –
 HOMA‑R 2.9 ± 3.2 –
 TG (mg/dl) 112.7 ± 50.2 120.0 ± 48.1 0.64
 HDL‑C (mg/dl) 46.1 ± 14.0 48.3 ± 7.7 0.43
 LDL‑C (mg/dl) 107.5 ± 27.2 114.0 ± 31.9 0.50
 Creatinine (mg/dl) 0.79 ± 0.19 0.74 ± 0.14 0.31
 eGFR ml/min./1.73 m2 78.1 ± 19.3 79.9 ± 13.3 0.69
Echocardiographic data
 Left atrial diameter (mm) 36.2 ± 4.4 33.5 ± 4.3 0.044
 RWT 0.43 ± 0.07 0.43 ± 0.06 0.72
 LV mass index (g/m2) 84.7 ± 21.4 77.1 ± 14.7 0.13
 LVEDV index (ml/m2) 55.8 ± 11.4 54.3 ± 8.9 0.61
 LVESV index (ml/m2) 18.2 ± 5.0 18.5 ± 3.3 0.81
 LVEF (%) 67.2 ± 5.1 65.6 ± 5.1 0.34
 E/A 0.9 ± 0.3 0.9 ± 0.2 0.42
 DT (msec) 194.8 ± 45.1 182.9 ± 42.0 0.37
 Septal e′ (cm/sec) 7.0 ± 2.2 7.9 ± 1.7 0.11
 E/e′ 9.3 ± 2.7 7.6 ± 1.1 0.0004
 MDV baseline (cm/sec) 15.3 ± 3.5 15.2 ± 3.9 0.89
 MDV hyperemia (cm/sec) 50.6 ± 12.6 56.8 ± 11.6 0.088














Fig. 3 Distribution of diastolic dysfunction in age‑matched controls 
and patients with type 2 diabetes.
Table 3 Univariate and  multivariate analysis of  the vari-
ables associated with E/e′ (n = 67)
Abbreviations as in Tables 1 and 2.
Variables Univariate Multivariate
β p β p
Age 0.36 0.0033 0.22 0.12
Female 0.21 0.086
BMI −0.048 0.70
Hypertension 0.32 0.0095 0.13 0.29
RPP −0.035 0.78
LVEF 0.17 0.17
LV mass index 0.33 0.0076 0.27 0.023











n = 67 
-0.34, p = 0.0055 






1 2 3 4 5 6
 Patients  
 Controls 
Fig. 4 Inverse association between CFR and surrogate marker of LV 
filling pressure (E/e′) in patients with type 2 diabetes.
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retinopathy has been reported to be associated with 
congestive heart failure or LV diastolic dysfunction in 
diabetic patients [13, 14]. Based on these findings, micro-
vascular abnormalities have been regarded as an impor-
tant cause of heart failure in diabetic patients. However, 
there are limited data on the direct relationship of coro-
nary microvascular function with LV diastolic function 
in patients with diabetes. Multivariate analysis in the 
present study showed that both LV mass index and CFR 
were independently associated with E/e′ in type 2 dia-
betic patients without overt cardiovascular disease. This 
result suggests that coronary microvascular disease is 
one of the determinants of LV diastolic dysfunction, rec-
ognized as an early change in diabetic cardiomyopathy. 
However, it is also possible that the LV diastolic dysfunc-
tion may have affected maximum coronary flow and CFR. 
Although our results fill an important gap in the earlier 
published data, the association between coronary micro-
vascular function and LV diastolic dysfunction does not 
prove that coronary microvascular function is the cause 
of LV diastolic dysfunction in patients with diabetes.
In the present study, CFR was significantly lower in dia-
betic patients than controls, and this result agrees with 
the previous studies. It is conceivable that the reduction 
of CFR in type 2 diabetes is a complex phenomenon that 
is related to several factors. Diabetic patients are known 
to have structural abnormalities in small vessels, includ-
ing a reduced capillary volume, fibrosis in vessel walls, 
and thickening of capillary basement membranes [32]. 
Although an experimental study indicated that endothe-
lium-dependent dilatation of the coronary microvascu-
lature at the early phase of diabetes is preserved despite 
increased oxidative stress [33], endothelial dysfunction 
due to oxidative stress, accumulated glycosylation end 
products, or activated protein kinase C may partially 
explain the reduced CFR observed in diabetic patients 
[32].
We used adenosine to assess CFR in this study. Because 
adenosine dilates coronary arterioles through adeno-
sine A2 receptors by increasing adenylate cyclase and 
decreasing calcium uptake [34], the blood flow response 
to adenosine is thought to be endothelium-independent. 
However, it has been reported that adenosine also acts, at 
least partially, as an endothelium-dependent vasodilator, 
both via flow-mediated dilation and via direct stimula-
tion of endothelial cells [35, 36]. We also reported previ-
ously that asymmetric dimethylarginine, an endogenous 
nitric oxide synthase inhibitor, was inversely associated 
with CFR in diabetic patients [37]. Therefore, adenosine-
induced CFR partially reflects coronary endothelial func-
tion [36].
Recently, a new paradigm [38] for heart failure with 
preserved ejection fraction has been proposed; a systemic 
proinflammatory state due to diabetes and comorbidities 
causes coronary microvascular endothelial inflamma-
tion, and this reduces nitric oxide bioavailability, cyclic 
guanosine monophosphate content, and protein kinase 
G activity in adjacent cardiomyocytes. Furthermore, low 
protein kinase G activity favors muscle fiber hypertrophy 
development and increases resting tension because of 
hypophosphorylation of titin, and both stiff cardiomyo-
cytes and interstitial fibrosis contribute to the develop-
ment of high diastolic LV stiffness and heart failure. This 
novel paradigm supports our findings, and the measure-
ment of CFR by echocardiography may be a noninvasive 
practical tool to assess coronary endothelial function in 
the clinical setting.
Contrary to previous reports [39], we failed to find a 
correlation between E/e′ and control parameters of dia-
betes such as fasting blood sugar, glycosylated hemo-
globin, immunoreactive insulin and HOMA-R in the 
present study. This result may be because of the small 
number of patients in the present study, differences in 
patients’ clinical backgrounds and/or the effect of treat-
ment. However, in subjects with albuminuria and nor-
mal LV ejection fraction, the HOPE study [40] indicated 
that heart failure risk greatly rises in patients with a high 
degree of albuminuria irrespective of the presence or 
absence of diabetes. This result suggests that the degree 
of microvascular disease due to diabetes or some other 
factor is associated with heart failure events rather than 
indices of glycemic control per se. Therefore, it is not 
surprising that there was no relationship between tem-
poral glycemic control and E/e′ in the present study. As 
for CFR, there was also no association between tempo-
ral glycemic control and CFR in the present study. As 
with albuminuria, CFR may be a summary measure of 
microvascular injury due to multiple risk factors includ-
ing diabetes. Furthermore, CFR is also associated with LV 
diastolic dysfunction in patients with arterial hyperten-
sion [41] and coronary artery disease [42], and an asso-
ciation between CFR and LV diastolic function may also 
occur in patients with various coronary risk factors.
Limitations
There are several important limitations of the present 
study. The presence of epicardial coronary stenosis was 
excluded based only on the absence of symptoms, no 
previous history of cardiovascular disease, and a nega-
tive exercise stress test. Advanced imaging modalities 
(e.g. stress myocardial perfusion scintigraphy, computed 
tomographic angiography, conventional coronary angi-
ography) were not applied. Therefore, we cannot be 
fully confident that we excluded patients with epicardial 
coronary stenosis. However, all of the studied patients 
had both a negative exercise stress test and CFR ≥2.0, 
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indicating that there was no significant LAD stenosis [22, 
23]. It has also been reported that CFR <2.0 by transtho-
racic Doppler echocardiography has a high predictive 
value for the presence of significant LAD stenosis, even 
in a population that includes patients with diabetes [43]. 
Therefore, we assumed that there was little likelihood of 
including patients with significant LAD stenosis in our 
study population. However, the exclusion of patients with 
CFR <2.0 may have excluded some patients with severe 
microvascular dysfunction, and this is an important study 
limitation. Moreover, CFR was measured only in the 
LAD. Although measurement of CFR in three coronary 
arteries is preferable, this remains technically challeng-
ing at the present time. However, coronary microcircula-
tory dysfunction affects the left ventricle globally as well 
as regionally [44]; therefore, CFR assessment in the LAD 
is an excellent option for evaluating the global coronary 
microcirculation. Although diabetic patients had signifi-
cantly lower CFR than controls, CFR in diabetics in this 
study was 3.3 and relatively high. Even if the 6 patients 
with CFR <2.0 were included, the mean value of CFR was 
still 3.1. The CFR value in similar subjects in our previous 
reports was 2.9 [17, 37]. This may be because of various 
differences in patients’ background. For example, only 
5 patients had microalbuminuria (>30  mg/g creatinine) 
in this study, and the microvascular damage in diabetic 
patients in the present study may not have been as severe 
as in our previous studies. Although E/e′ is now widely 
recognized as a surrogate marker of LV filling pressure, 
particularly in patients with preserved LV ejection frac-
tion, LV filling pressure was not confirmed by invasive 
methods in the present study.
Conclusion
Coronary microvascular function was independently 
associated with LV filling pressure in patients with type 
2 diabetes but without overt cardiovascular disease. 
This result suggests a possible link between coronary 
microvascular disease and LV diastolic function in these 
subjects.
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